Biotech Better Than Pharma For Combo Product Partnerships?
This article was originally published in The Gray Sheet
Executive Summary
Device makers may find more suitable partners for developing combination products in biotechnology firms, as opposed to pharmaceutical giants with fundamentally different business models, according to Medtronic's Lothar Krinke
You may also be interested in...
Medtronic InFuse Bone Graft Is “Approvable” For Oral Use – FDA Dental Panel
A possible reduction in morbidity associated with use of Medtronic's InFuse bone graft compared with conventional autograft treatment for oromaxillofacial bone defects outweighs potentially reduced efficacy of up to 20% and justifies FDA approval, the agency's Dental Products Panel agreed Nov. 9
Medtronic Gets To Heart Of Cell Therapy Through Genzyme Collaboration
Medtronic will draw on expertise from its three cardiac-related divisions to aid Genzyme in the development of a catheter-delivered cell therapy for cardiovascular disease
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.